Dhampur Bio (India) Today

DBOL Stock   126.64  1.10  0.88%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
Dhampur Bio is selling for under 126.64 as of the 27th of November 2024; that is 0.88 percent increase since the beginning of the trading day. The stock's lowest day price was 125.12. Dhampur Bio has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Dhampur Bio Organics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of October 2024 and ending today, the 27th of November 2024. Click here to learn more.
Business Domain
Food, Beverage & Tobacco
Category
Consumer Defensive
Classification
Consumer Staples
Dhampur Bio is entity of India. It is traded as Stock on NSE exchange. The company has 66.39 M outstanding shares. More on Dhampur Bio Organics

Moving against Dhampur Stock

  0.57NSIL Nalwa Sons InvestmentsPairCorr
  0.49NBIFIN N B IPairCorr
  0.48PILANIINVS Pilani InvestmentPairCorr
  0.44JSWHL JSW Holdings LimitedPairCorr
  0.35VHL Vardhman HoldingsPairCorr

Dhampur Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Dhampur Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Dhampur Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Executive ChairmanVijay Goel
Thematic IdeaNatural Foods (View all Themes)
Business ConcentrationAgricultural Products & Services, Food, Beverage & Tobacco, Consumer Defensive, Natural Foods, Consumer Staples, Food Products, Farm Products, Consumer Defensive (View all Sectors)
Dhampur Bio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Dhampur Bio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Dhampur Bio can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Dhampur Bio's financial leverage. It provides some insight into what part of Dhampur Bio's total assets is financed by creditors.
Liquidity
Dhampur Bio cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Dhampur Bio Organics has accumulated 10.57 B in total debt. Debt can assist Dhampur Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Dhampur Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Dhampur Bio Organics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Dhampur to invest in growth at high rates of return. When we think about Dhampur Bio's use of debt, we should always consider it together with cash and equity.

End Period Cash Flow

56.91 Million
Dhampur Bio Organics (DBOL) is traded on National Stock Exchange of India in India and employs 1,637 people. Dhampur Bio is listed under Agricultural Products & Services category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.4 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Dhampur Bio's market, we take the total number of its shares issued and multiply it by Dhampur Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Dhampur Bio Organics operates under Food Products sector and is part of Consumer Staples industry. The entity has 66.39 M outstanding shares. Dhampur Bio generates negative cash flow from operations
Check Dhampur Bio Probability Of Bankruptcy
Ownership Allocation
Dhampur Bio holds a total of 66.39 Million outstanding shares. Dhampur Bio Organics shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.42 percent of Dhampur Bio Organics outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Dhampur Ownership Details

Dhampur Bio Organics Risk Profiles

Although Dhampur Bio's alpha and beta are two of the key measurements used to evaluate Dhampur Bio's performance over the market, the standard measures of volatility play an important role as well.

Dhampur Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Dhampur Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Dhampur Bio Corporate Management

Elected by the shareholders, the Dhampur Bio's board of directors comprises two types of representatives: Dhampur Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Dhampur. The board's role is to monitor Dhampur Bio's management team and ensure that shareholders' interests are well served. Dhampur Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Dhampur Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ashoo BanerjeeChief OfficerProfile
Charu KoharwalChief EngineeringProfile
Sudeep BanerjeeChief OfficerProfile
Nalin GuptaChief OfficerProfile

Additional Tools for Dhampur Stock Analysis

When running Dhampur Bio's price analysis, check to measure Dhampur Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dhampur Bio is operating at the current time. Most of Dhampur Bio's value examination focuses on studying past and present price action to predict the probability of Dhampur Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dhampur Bio's price. Additionally, you may evaluate how the addition of Dhampur Bio to your portfolios can decrease your overall portfolio volatility.